ライフサイエンスコーパス: operable

1 ies or radiation therapies, and they are not operable.

2 egions indicating that repair mechanisms are operable.

3 th acid and base catalyzed mechanisms may be operable.

4 uggest that a reductive quenching pathway is operable.

5 ve quenching pathway of the photocatalyst is operable.

6 and 6151 (80%) cases that were high-risk but operable.

7 luded thrombophilic disorder in 31.9% (37.1% operable, 23.5% nonoperable) and splenectomy in 3.4% of

8 mptoms; 427 patients (62.9%) were considered operable, 247 (36.4%) nonoperable, and 5 (0.7%) had no o

9 e) and splenectomy in 3.4% of patients (1.9% operable, 5.7% nonoperable).

10 rterial hypertension-targeted therapy (28.3% operable, 53.8% nonoperable).

11 sm was reported for 74.8% of patients (77.5% operable, 70.0% nonoperable).

12 1350 patients with operable adenocarcinoma of the rectum were randomly assi

13 isease, because it renders inoperable tumors operable and increases the rates of breast-conserving su

14 spite similarities in clinical presentation, operable and nonoperable CTEPH patients may have distinc

15 tries, and a substantial number of patients (operable and nonoperable) receive off-label pulmonary ar

16 ant features of gene fusion data in an inter-operable and query-able fashion that will enable biologi

17 ed, primary retroperitoneal sarcoma that was operable and suitable for radiotherapy, who had not been

18 the relief of glucose repression is already operable at much higher glucose concentrations than is w

19 e terahertz waves in a chip-scale technology operable at room temperature has potential for transform

20 of externally addressable spintronic devices operable at room temperature.

21 nanoscale magnetic resonance imaging that is operable at room temperature.

22 ng a low HTT solid-phase formation mechanism operable at temperatures commonly used for industrial bi

23 rmed, HER2-positive, stage I-IIIA, invasive, operable breast cancer ( 1.5 cm tumour size) with at lea

24 ntrally confirmed HER2-positive stage II-III operable breast cancer (>2 cm tumour size), an Eastern C

25 NAC for operable breast cancer (BC) can downstage disease and fa

26 Women with operable breast cancer (N = 2,411) were randomly assigne

27 Preoperative systemic therapy (PST) in operable breast cancer allows a small increase in breast

28 cycles of AC alone in patients with resected operable breast cancer and histologically positive axill

29 After surgical treatment, 3,121 women with operable breast cancer and involved lymph nodes were ran

30 Women with operable breast cancer and multicentric tumors, with duc

31 Women with operable breast cancer and multicentric tumors, with duc

32 and preclinical and clinical data of PST in operable breast cancer and the potential role of interme

33 for the different clinical presentations of operable breast cancer and to present quantitative progn

34 s from adjuvant therapies in such women with operable breast cancer are unknown.

35 Chinese women with hormone receptor-positive operable breast cancer benefit from adjuvant treatment w

36 mone receptor-positive, lymph node-positive, operable breast cancer between December 2007 and October

37 Chemotherapy for operable breast cancer decreases the risk of death.

38 receptor-positive, lymph node-positive, and operable breast cancer for which they had undergone loca

39 Preoperative chemotherapy in operable breast cancer has been shown to improve breast

40 ng use of neoadjuvant chemotherapy (NAC) for operable breast cancer has raised questions about optima

41 dronate trials in different populations with operable breast cancer have been mixed.

42 clinical trials (RCTs) of PST for palpable, operable breast cancer have been reported since 1991 (fr

43 d well tolerated as tamoxifen in ER-positive operable breast cancer in postmenopausal women, but the

44 pants in this phase III randomized study had operable breast cancer involving four or more axillary l

45 In premenopausal women with operable breast cancer not selected for estrogen recepto

46 ous even within clinically similar groups of operable breast cancer patients.

47 We deemed eligible all patients with operable breast cancer presenting at The University of T

48 Systemic chemotherapy for operable breast cancer substantially decreases the risk

49 All patients with operable breast cancer that were eligible for a SLNB fro

50 9, we recruited 709 premenopausal women with operable breast cancer to a multisite randomized clinica

51 ide treatment in patients with HER2-positive operable breast cancer to determine whether there would

52 ve or high-risk node-negative HER2-positive, operable breast cancer to receive either pertuzumab or p

53 pants comprised 53 015 patients with primary operable breast cancer treated from 2003 to 2012.

54 res for individual patients with HR-positive operable breast cancer treated with chemohormonal therap

55 In all, 4,046 patients with HER2-positive operable breast cancer were enrolled to receive doxorubi

56 ce status 0-1 and hormone receptor-positive, operable breast cancer were randomly assigned (2:1) to P

57 Patients with HER2-positive operable breast cancer were randomly assigned to doxorub

58 two patients with HER2-positive disease with operable breast cancer were randomly assigned to either

59 and operable or locally advanced potentially operable breast cancer were randomly assigned to neoadju

60 survival among patients with HER2-positive, operable breast cancer when it was added to trastuzumab

61 Patients with operable breast cancer with 0 to 3 positive nodes were e

62 HER2 negative; and have previously untreated operable breast cancer with adequate organ function.

63 factor receptor 2 (HER2)-positive, invasive, operable breast cancer with at least 1 breast lesion eva

64 irmed, HER2-positive, stage I-IIIA invasive, operable breast cancer with at least one PET-evaluable l

65 Women diagnosed with operable breast cancer within 3 months underwent FDG-PET

66 Among patients with high-risk operable breast cancer without diabetes, the addition of

67 seem to provide any benefit to patients with operable breast cancer, and should not change clinical p

68 r (ER)-positive, HER2-negative, stage I-III, operable breast cancer, from 85 hospitals in 22 countrie

69 med node-positive or high-risk node-negative operable breast cancer, had undergone complete excision,

70 Clodronate, given to patients with primary operable breast cancer, may reduce the occurrence of bon

71 In operable breast cancer, preoperative systemic therapy is

72 In operable breast cancer, there seems to be no survival ad

73 c (modified to stage 2-3c in February, 2010) operable breast cancer, who had completed neoadjuvant an

74 eceptor 2 (HER2) -positive, stage II to IIIA operable breast cancer.

75 ed disease-free survival compared with AC in operable breast cancer.

76 is being used with increasing frequency for operable breast cancer.

77 BRCA pathogenic variant (gBRCA-positive) and operable breast cancer.

78 redicted for improved survival in women with operable breast cancer.

79 bareolar technique for SLNB in patients with operable breast cancer.

80 d clinical and pathologic response rates for operable breast cancer.

81 ease-free and overall survival of women with operable breast cancer.

82 linical stage, and lymph node involvement in operable breast cancer.

83 cular invasion and early tumor metastasis in operable breast cancer.

84 ausal women with node-positive, ER-positive, operable breast cancer.

85 r OS in neoadjuvant trials of HER2-positive, operable breast cancer.

86 l to improving outcomes in hormone sensitive operable breast cancer.

87 follow-up of 24 years from the diagnosis of operable breast cancer.

88 associated with poor outcomes in women with operable breast cancer.

89 al growth factor receptor 2 (HER2) -negative operable breast cancer.

90 and ER expression in patients with primary, operable breast cancer.

91 would improve relapse-free survival (RFS) in operable breast cancer.

92 tdiagnosis among 53 premenopausal women with operable breast carcinoma.

93 uding whether concomitant treatment of TR in operable but high-risk patients with aortic stenosis is

94 ure, causes and obstacles that may have been operable but were not found in the literature were also

95 g force for substrate oxidation, an ET/PT is operable, but once ET (i.e., substrate one-electron oxid

96 The method is easily operable by a single person from a small boat, and the s

97 We adapted the assay to make it portable and operable by a smartphone.

98 Clinical trials supported the thesis that operable cancer is a systemic disease and that variation

99 ould substantially increase CTC detection in operable cancer patients.

100 iated with reduced survival in patients with operable cancer.

101 ion based prognostic scores in patients with operable cancers.

102 hypertensive medical therapy (PHT) exists in operable candidates.

103 lymph node metastasis and poor prognosis in operable cases of pancreatic ductal adenocarcinoma (PDAC

104 Operable cell or tissue models are either generally lack

105 Versus Balloon Pulmonary Angioplasty in Non-Operable Chronic Thromboembolic Pulmonary Hypertension)

106 he gold standard treatment for patients with operable chronic thromboembolic pulmonary hypertension.

107 xaliplatin-fluoropyrimidine chemotherapy for operable colon cancer can be delivered safely, without i

108 of cetuximab to chemotherapy and surgery for operable colorectal liver metastases in KRAS exon 2 wild

109 It is also operable cost-effectively in the absence of supporting e

110 steatosis, and the host SIR in patients with operable CRC.

111 both S(N)1- and S(N)2-type mechanisms may be operable depending on substitution at silicon.

112 best results, allowing definition of Method Operable Design Region and quantitation of the total amo

113 f minimally invasive surgical techniques for operable disease and integration of immune checkpoint in

114 n the perioperative setting in patients with operable disease confers a significant disadvantage in t

115 s four of five studies of only patients with operable disease showed no significant relation.

116 focus on recent updates in the treatment of operable disease, and an overview of the most recent pro

117 In patients of low operative risk and operable disease, surgery should be considered to improv

118 ing evaluated in patients with earlier-stage operable disease.

119 hese novel approaches into the management of operable disease.

120 nalyzed tumor samples from 953 patients with operable EAC for expression of the basal cytokeratins CK

121 ith node-positive or high-risk node-negative operable early breast cancer were randomly assigned by c

122 extended to include patients with large but operable early-stage breast cancer, with the possibility

123 ve radiotherapy (SABR) than with surgery for operable early-stage non-small-cell lung cancer (NSCLC),

124 eoperative chemotherapy improves survival in operable esophageal cancer and should be considered as a

125 th surgery alone for patients with local and operable esophageal cancer.

126 point blockade (ICB) demonstrates promise in operable esophageal squamous cell carcinoma (ESCC), but

127 l, postmenopausal women with newly diagnosed operable estrogen receptor-positive, human epidermal gro

128 junction with the microfluidic device and is operable even with a reversible seal.

129 tion creates two connected yet independently operable fluidic loops.

130 Non-early operable gastric cancer is treated with surgery, which s

131 of perioperative treatment in patients with operable gastric cancer.

132 3 lymphadenectomy) in patients affected with operable gastric carcinoma?

133 In patients with operable gastric or lower esophageal adenocarcinomas, a

134 perioperative chemotherapy plus surgery for operable gastroesophageal cancer from July 1, 1994, thro

135 urrence-free survival (RFS) of patients with operable gastrointestinal stromal tumor (GIST) compared

136 protocol using paclitaxel with cisplatin in operable head and neck cancers have been reported.

137 operative treatment in patients with primary operable HER2-negative early breast cancer.

138 men aged 18 years or older with stage I-IIIa operable HER2-positive breast cancer from 112 centres in

139 th an ECOG performance status of 0 or 1 with operable HER2-positive breast cancer.

140 Women with operable HER2-positive invasive breast cancer were rando

141 therapy would improve outcomes in women with operable, HER2-negative breast cancer and whether adding

142 enrolled women aged 18 years or older, with operable, HER2-non-amplified invasive adenocarcinoma of

143 Valve) I trial, 657 patients from cohort A (operable high risk) were randomly assigned to SAVR or TA

144 cohort B [inoperable] and 242 from cohort A [operable high-risk]) were randomly assigned to TF-TAVR a

145 s; HER2-amplified early stage breast cancer; operable, histologically confirmed, invasive carcinoma o

146 had performance status [PS] of 0 to 1) with operable, histologically confirmed, stage I to III adeno

147 ndomly assigned 257 premenopausal women with operable hormone-receptor-negative breast cancer to rece

148 omplete response in the breast in women with operable, human epidermal growth factor receptor 2 (HER2

149 These accumulation defects also appear operable in acute lymphoblastic leukemia.

150 ve useful in dissecting the molecular events operable in the development of neoplasms induced by bact

151 The development of sensors operable in these solvents is highly beneficial to the c

152 cates that an oxidative quenching pathway is operable in this broadly applicable fluorination protoco

153 s that two discrete reaction pathways can be operable in this process depending upon the nature of th

154 sponse to glycosylation inhibition, which is operable in WEHI7.2 cells.

155 neoadjuvant trial, 32 biological males with operable intermediate to high-risk localized PCa were en

156 evaluated NAC use in patients with initially operable invasive breast cancer and potential impact on

157 nts were eligible if they had stage I to III operable invasive breast cancer with complete surgical e

158 ients had (1) stage IA to IIIC biopsy-proven operable invasive breast cancer; (2) standard-of-care NA

159 n 70 years from a consecutive series of 1944 operable invasive breast cancers.

160 To test this theory, 68 patients with 69 operable invasive breast carcinomas and clinically node-

161 ning biopsies from 483 patients with primary operable invasive ductal breast cancer was stained by im

162 brain metastases in patients with clinically operable known or possible NSCLC and a large (> 3-cm) lu

163 th multiple agents as well as surgery of all operable lesions.

164 Patients with operable, localized gastric, or gastroesophageal adenoca

165 ality/trimodality treatment of patients with operable locally advanced non-small-cell lung cancer.

166 ntre using dynamic allocation, stratified by operable, locally advanced, and inflammatory breast canc

167 performance status of 0 or 1, HER2-positive, operable, locally advanced, or inflammatory stage II-III

168 ntify the first station of nodal drainage of operable lung cancers.

169 e-free and overall survival among women with operable lymph-node-positive breast cancer.

170 dance of wind speeds that can be twice their operable maxima.

171 single decision tree model that provided an operable method for stratifying sub-populations.

172 leted in 15 min, the technique results in an operable microdevice with micrometer-scale features of n

173 platin-fit patients with stage cT2-T4a cN0-1 operable MIUC.

174 retrospective cohort study of patients with operable MPM, there was significant variability in acces

175 n the overall survival (OS) of patients with operable MPM.

176 Patients with operable node-positive BC (T1-3/N1-3) were eligible.

177 Cytoxan) improves survival in patients with operable node-positive disease.

178 We randomly assigned 5351 patients with operable, node-positive, early-stage breast cancer to re

179 Eligible patients were those with operable, node-positive-or node negative with tumor 1 cm

180 esponse rates than CT alone in patients with operable non-small cell lung cancer (NSCLC).

181 ned to investigate whether, in patients with operable non-small cell lung cancer of any stage, outcom

182 s obtained for consecutive participants with operable non-small cell lung cancer.

183 een the standard treatment for patients with operable non-small-cell lung cancer (NSCLC).

184 chemotherapy after surgery for patients with operable non-small-cell lung cancer improves survival, i

185 gated the effect of adjuvant chemotherapy in operable non-small-cell lung cancer.

186 icin and cisplatin might produce survival of operable, non-metastatic osteosarcoma similar to that ob

187 407 patients with operable, non-metastatic osteosarcoma were randomly assi

188 ween the two-drug and multi-drug regimens in operable, non-metastatic osteosarcoma.

189 involvement of lymph nodes in patients with operable NSCLC although the impact of neoadjuvant immune

190 and impact on the immune microenvironment in operable NSCLC remain unclear.

191 umab followed by surgery in 44 patients with operable NSCLC, using major pathologic response (MPR) as

192 ogic responses and warrants further study in operable NSCLC.

193 memory, and merits further investigation in operable NSCLC.

194 ere those with clinical T1-2a (<4 cm), N0M0, operable NSCLC.

195 ced 25 spatially distinct regions from seven operable NSCLCs and found evidence of branched evolution

196 potential to improve outcomes in women with operable oestrogen receptor-positive primary breast canc

197 emonstrated that two distinct mechanisms are operable on metallic Cu electrodes in acidic electrolyte

198 ents who are considered operable or probably operable on the basis of computed tomography and in the

199 th ER-positive, invasive, nonmetastatic, and operable or locally advanced potentially operable breast

200 otomy staging of patients who are considered operable or probably operable on the basis of computed t

201 s a disease that presents late and rarely is operable or resectable.

202 Sentinel node (SN) biopsy is accurate in operable oral and oropharyngeal cT1-T2N0 cancer (OC), bu

203 inical trial of neoadjuvant chemotherapy for operable osteosarcoma and the experience of two groups w

204 Here we report a commercially operable paternal HI line in wheat with a ~7% HI rate, i

205 a multicentre, phase III trial that included operable patients (pts), with cT2-cT3b low-mid rectal AD

206 mised studies comparing SABR with surgery in operable patients are warranted.

207 Operable patients did not differ from nonoperable patien

208 From 1995 to 2009, 222 operable patients had a cCR based on the results of a co

209 After complete urologic evaluation, operable patients who achieved complete response were se

210 Initially, operable patients with early-stage NSCLC (n = 15) were e

211 Operable patients with localized gastric adenocarcinoma

212 Operable patients with locally advanced esophageal cance

213 once regarded as the treatment of choice in operable patients with massive hemoptysis.

214 High-risk operable patients with NSCLC </= 3 cm were randomly assi

215 emotherapy and to salvage the occasional non-operable patients with recurrent and chemoresistant dise

216 Fourteen operable patients with residual tumor underwent immediat

217 ents, and a recommended therapy in high-risk operable patients with symptomatic severe aortic stenosi

218 7 per patient but misses 1.7% of potentially operable patients.

219 therapy of choice for acute cholecystitis in operable patients.

220 R in carefully selected high-risk, but still operable, patients in whom morbidity and mortality may b

221 olytic and denaturing agents, and extend the operable pH range for catalase activity.

222 Women (N = 2,411) with operable primary breast cancer were randomly assigned to

223 therapy, chemotherapy), in the management of operable primary breast cancer with ostensibly good prog

224 for radiologically staged, locally advanced operable primary colon cancer is feasible with acceptabl

225 inflammatory response (SIR) in patients with operable primary colorectal cancer (CRC).

226 nts with centrally confirmed triple-negative operable primary invasive breast cancer from 360 sites i

227 Maintaining pH in an operable range is key in many industrial processes, wher

228 unctional desensitization in the same set of operable receptors.

229 Local recurrence rates in operable rectal cancer are improved by radiotherapy (wit

230 pathological protocol in 1156 patients with operable rectal cancer from the CR07 and NCIC-CTG CO16 t

231 eatment is feasible in poor-risk potentially operable rectal cancer, with acceptable safety and promi

232 scores and composite ratios in patients with operable rectal cancer.

233 he risk of local recurrence in patients with operable rectal cancer.

234 is an effective treatment for patients with operable rectal cancer.

235 been shown to be prognostic in patients with operable rectal cancer.

236 section is considered standard treatment for operable rectal carcinoma, the optimal time to administe

237 In the operable setting, efforts to improve outcomes have focus

238 m 1988 to 1994, 68 patients with potentially operable squamous cell carcinoma of the esophagus were e

239 sed, phase 3 trials of SABR in patients with operable stage I NSCLC (STARS and ROSEL) closed early du

240 SABR could be an option for treating operable stage I NSCLC.

241 We included 752 operable stage I-III breast cancer patients representing

242 ative pazopanib monotherapy in patients with operable stage I/II NSCLC.

243 al guidelines have recommended patients with operable stage IA NSCLC to consider delaying surgery by

244 fter SABR is non-inferior to VATS L-MLND for operable stage IA NSCLC.

245 ng of clinical stage IIA and IIB and primary operable stage IIIA breast cancer?

246 hemoradiotherapy, surgery) for patients with operable stage IIIA non-small-cell lung cancer (NSCLC).

247 fter mediastinoscopic staging, patients with operable stage IIIA NSCLC were enrolled to a German mult

248 from a group of 315 patients suffering from operable (stage I and II) breast cancer with 20-years fo

249 The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC) is

250 ciated phase separation into X(2) limits the operable state of charge (SoC), results in vaporization

251 hting Network will have reached a stationary operable state, and is fairly robust against different c

252 noperable status (in 2011) and high-risk but operable status (starting in 2012).

253 ns the standard of care for the treatment of operable, symptomatic aortic valve disease; however, to

254 ts either died suddenly (n = 4) or developed operable symptoms only (n = 22) or subnormal LV performa

255 t cancer, even for patients who present with operable (T1 or T2) disease.

256 ary invasive breast cancer (stage T1, T2, or operable T3) with up to three positive lymph nodes, no d

257 d energy density, simple packaging, and wide operable temperature range.

258 It provides a simple, locally operable tool to aid policy makers in priority setting i

259 were compared: Cohort A patients (high-risk operable) treated by either TAVR (n = 149) or surgical a

260 ease-free (DFS) and overall survival (OS) in operable triple-negative breast cancer (TNBC).

261 Operable triple-negative breast cancers (TNBCs) have a h

262 ceptable alternative to women with palpable, operable tumors and an excellent arena for clinical tria

263 Surgery remains the treatment of choice for operable tumors, whereas chemotherapy is standard in loc

264 Flexible dielectrics operable under simultaneous electric and thermal extreme

265 nce level, and violation of the perceivable, operable, understandable, and robust (POUR) principles a

266 adjuvant atezolizumab versus observation in operable urothelial cancer.

267 mperature (and energy) recycling conditions, operable using neat polymers, to deliver both high monom

268 aphy videoangiography (ICG-VA) imaging, also operable via SurgeON, we found that direct-LSCI can prod

269 nnel blockade, if indicated; and surgery, if operable) were treated with chronic PGI2.